Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma.
about
Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma.Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinomaFactors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy.Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies.Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy.Role of Systemic Therapy and Future Directions for Hepatocellular Carcinoma.
P2860
Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Biochemical modulation of doxo ...... nced hepatocellular carcinoma.
@ast
Biochemical modulation of doxo ...... nced hepatocellular carcinoma.
@en
type
label
Biochemical modulation of doxo ...... nced hepatocellular carcinoma.
@ast
Biochemical modulation of doxo ...... nced hepatocellular carcinoma.
@en
prefLabel
Biochemical modulation of doxo ...... nced hepatocellular carcinoma.
@ast
Biochemical modulation of doxo ...... nced hepatocellular carcinoma.
@en
P2093
P1476
Biochemical modulation of doxo ...... nced hepatocellular carcinoma.
@en
P2093
P304
P577
1998-11-01T00:00:00Z